Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$0.35.

  • Envoy Medical's EPS (Basic) rose 1025.64% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.36, marking a year-over-year decrease of 1623.93%. This contributed to the annual value of -$1.49 for FY2024, which is 4146.46% up from last year.
  • Envoy Medical's EPS (Basic) amounted to -$0.35 in Q3 2025, which was up 1025.64% from -$0.32 recorded in Q2 2025.
  • Envoy Medical's EPS (Basic)'s 5-year high stood at $0.23 during Q1 2022, with a 5-year trough of -$1.31 in Q2 2023.
  • In the last 4 years, Envoy Medical's EPS (Basic) had a median value of -$0.35 in 2025 and averaged -$0.37.
  • The largest annual percentage gain for Envoy Medical's EPS (Basic) in the last 5 years was 20000.0% (2023), contrasted with its biggest fall of 228333.33% (2023).
  • Quarter analysis of 4 years shows Envoy Medical's EPS (Basic) stood at -$1.13 in 2022, then surged by 55.0% to -$0.51 in 2023, then grew by 19.54% to -$0.41 in 2024, then rose by 14.73% to -$0.35 in 2025.
  • Its EPS (Basic) stands at -$0.35 for Q3 2025, versus -$0.32 for Q2 2025 and -$0.29 for Q1 2025.